Orapred Tablet Formulation Gets FDA Nod

BioMarin corticosteroid asthma treatment will be marketed by Alliant in North America.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet